logical Council of the Siberian Branch of RAS, which coordinates research at biological academic institutes in Siberia. He has more than 300 scientific publications that include research on RNA structure, antisense technologies, and circulating nucleic acids. He has received several awards, including the State Prize for scientific achievement. Current activity is focused on development of approaches for translational medicine, including postgenomic technologies-based diagnostic methods, design of gene-targeted therapeutics, and cell technologies.
Kavita M. Berger is the associate program director of the Center for Science, Technology, and Security Policy at the American Association for the Advancement of Science (AAAS). Since joining AAAS in 2006, she has addressed complex biosecurity policy issues, such as personnel reliability and misuse of biological research, by actively interacting with the scientific community, facilitating open dialogue between the scientific and security communities, and providing a voice for the scientific community in timely policy debates. Through these projects and other activities, she has helped enable scientists to contribute to addressing biosecurity risks at the local, national, and international levels. During a short absence from AAAS, she worked with the Presidential Commission for the Study of Bioethical Issues as the staff lead on evaluation of the ethical issues associated with pediatric medical countermeasures research. She received her Ph.D. degree in genetics and molecular biology at Emory University and conducted her postdoctoral research on preclinical research and development on HIV and smallpox vaccines.
David Franz (Consultant) has recently served as vice president and chief biological scientist of MRIGlobal and senior advisor (biosecurity engagement) to the Office of the Assistant to the Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. Dr. Franz was the chief inspector on three UN Special Commission biological warfare missions to Iraq and served as technical advisor on long-term monitoring. He also served as a member of the first two U.S.-U.K. teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons and as a member of the Trilateral Experts’ Committee for biological weapons negotiations. Dr. Franz served in the U.S. Army Medical Research and Materiel Command for 23 of 27 years on active duty and retired as colonel. He served as commander of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and as deputy commander of the Medical Research and Materiel Command. Prior to joining the Command, he served as group veterinarian for the 10th Special Forces Group (Airborne). The current focus of his activities relates to the role of international engagement in the life sciences as a component of national security policy. Dr. Franz holds a D.V.M. from Kansas State University and a Ph.D. in physiology from Baylor College of Medicine.